A new joint Australian-Chinese Research
Center aims to understand traditional Chinese medicine at the molecular level,
with the ultimate aim of its integration into Western medicine.
A new
joint Australian-Chinese Research Center announced in Beijing last week aims to
understand traditional Chinese medicine at the molecular level, with the
ultimate aim of its integration into Western medicine.
The
Zhendong Australia China Center for Molecular Traditional Chinese Medicine is a
joint Center between the University of Adelaide, the Shanxi College of
Traditional Chinese Medicine, and the Zhendong Pharmaceutical Company.
At the
Beijing ceremony, guests included the Vice Minister of Health and Director of
the State Administration of Traditional Chinese Medicine Wang Guoqiang,
Australian Ambassador to China Frances Adamson, Executive Chairman of China
Pharmaceutical Industry Research and Development Association Song Ruilin,
Shanxi College of Traditional Chinese Medicine President Professor Zhou Ran,
Zhendong Pharmaceutical Company Chairman Li Anping, and University of Adelaide
Vice-Chancellor and President Professor James McWha.
The
special event on Friday also marked the 40th anniversary of diplomatic
relations between Australia and China.
“This
significant partnership offers a unique model of operation; bringing together
an Australian university, a Chinese university, and direct investment from a
Chinese company in a ground-breaking development that offers tremendous
opportunities for creative research and new discoveries with potential health
benefits for us all,” said University of Adelaide Vice-Chancellor and President
Professor James McWha.
At the
University of Adelaide, the Zhendong Center will investigate the mode of action
of traditional Chinese medicine using a systems biology approach.
“The
application of systems biology to traditional Chinese medicine is particularly
exciting because it explores what effects there may be on the molecular/genetic
networks that are altered in sickness,” said Director of the Zhendong Center,
Professor David Adelson.
Understanding
how traditional Chinese medicine acts will not only support its evidence-based
integration into Western medicine, but also increase our understanding of the
molecular mechanisms underlying disease, said Adelson.
Professor
Adelson has also been appointed Chair for the Molecular Basis of Traditional
Chinese Medicine, a new Chair endowed by Zhendong Pharmaceutical Company as
part of its investment in this research.
Source: University of Adelaide.
No comments:
Post a Comment